UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - sherie+morrison
4
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Targeted Delivery of IFN-gamma Using Antibody Fusion Proteins (UCLA Case No. 2017-543)
UCLA researchers in the Departments of Microbiology, Immunology & Molecular Genetics (MIMG) and Medicine have developed antibody–cytokine fusion proteins that enable the targeted delivery of active interferon-gamma (IFNγ) for cancer treatment. Interferon-gamma (IFNγ), a type II interferon, is a cytokine released by both natural...
Published: 2/26/2024
|
Inventor(s):
Sherie Morrison
,
John Timmerman
,
Kham (Ryan) Trinh
Keywords(s):
Antibody Delivery Platforms
,
Drug Delivery
,
Immunotherapy
,
Life Science Research Tools
,
Therapeutics & Vaccines
Category(s):
Therapeutics
,
Platforms > Drug Delivery
,
Platforms > Drug Delivery > Antibody Delivery Platforms
,
Life Science Research Tools
,
Therapeutics > Immunology And Immunotherapy
2018-384 ANTIBODY-INTERFERON FUSION PROTEINS FOR ENHANCING ADOPTIVE T CELL THERAPIES FOR THE TREATMENT OF CANCER
UCLA researchers in the Departments of Medicine and Microbiology, Immunology and Molecular Genetics have developed a novel combination therapy for enhanced efficacy of Adoptive T Cell Therapies (ACT): that could enable the adoption of ACT as an effective means to combat multiple cancer subtypes. BACKGROUND:The clinical relevancy of cancer immunotherapy...
Published: 7/19/2023
|
Inventor(s):
John Timmerman
,
Patricia Young
,
Kham (Ryan) Trinh
,
Sherie Morrison
Keywords(s):
Diagnostic Markers & Platforms
,
Oncology
,
Therapeutics & Vaccines
Category(s):
Diagnostic Markers
,
Therapeutics
,
Therapeutics > Oncology
Improved Rh (D) Human Blood Typing Reagent
Case 1999-354In situations such as blood transfusions and pregnancy, contact between different sources of blood makes it necessary to screen blood types to identify mutually incompatible immunogenic factors. Standard hemagglutination tests for blood typing are slower and more complicated in the case of the Rh (D) red blood cell (RBC) factor, however,...
Published: 7/19/2023
|
Inventor(s):
Sherie Morrison
,
Ramon Montano
Keywords(s):
Diagnostic Markers & Platforms
,
Medical Devices and Materials
Category(s):
Diagnostic Markers
,
Medical Devices
Hybrid IgA/IgG Polymeric Antibodies
Case 1998-610BACKGROUNDIgA is a polymeric effector molecule of the immune system that mainly acts at mucosal surfaces and is highly resistant to extreme pH conditions, whereas IgG is monomeric and acts in the blood at a narrower pH range. IgG is known for its potent complement activation and, in contrast, IgA is unable to fix complement. Combining the...
Published: 7/19/2023
|
Inventor(s):
Sherie Morrison
,
Koteswara Chintalacharuvu
,
Maria Coloma
,
Kham (Ryan) Trinh
,
Esther Yoo
Keywords(s):
Antibodies
,
Immunotherapy
Category(s):
Life Science Research Tools > Antibodies
,
Therapeutics > Immunology And Immunotherapy